Navigation Links
Virus Unlikely to Advance Deadly Lung Disease: Study
Date:2/25/2011

FRIDAY, Feb. 25 (HealthDay News) -- Most patients struggling with a progressive and fatal form of lung disease called idiopathic pulmonary fibrosis do not risk a worsening of their condition as a result of exposure to a viral infection, new research indicates.

The finding contradicts prior investigations that had suggested viral infections might rapidly advance disease in patients diagnosed with idiopathic pulmonary fibrosis (IPF).

"The results of this study suggest that the majority of cases of acute exacerbation of IPF are not due to viral infection," study author Dr. Harold Collard, director of the Interstitial Lung Disease Program at the University of California, San Francisco (UCSF), said in a news release from the American Thoracic Society.

Collard and colleagues from the United States, Korea and Japan report their observations online in advance of publication in an upcoming print issue of the American Journal of Respiratory and Critical Care Medicine.

The authors noted that IPF is characterized by the thickening and scarring of the lungs, and most often affects men and women in their 50s, 60s and 70s.

The stiffening of lung tissue that occurs in those with the disease ultimately compromises respiratory function. In some cases, the ongoing and debilitating process unfolds slowly. However, in others, a more aggressive process takes hold in the form of an "acute" phase with more rapid consequences.

To see whether or not a viral infection might trigger the onset of this acute process, between 2006 and 2009, Collard's team focused on 43 patients from two health facilities, all of whom had already been diagnosed with the harsher and speedier form of the disease. For comparison, 69 patients from a different medical center were also included, all of whom were diagnosed with either the slower-moving ("stable") form of IPF or, alternatively, an acute lung injury.

After collecting lung fluid and blood samples from all of the patients, the investigators performed a series of high-tech DNA tests to look for signs of viral infection.

The results: while no evidence of viral infection was found in the "stable" IPF patients, only four of the "acute" IPF patients were infected with a tell-tale common respiratory virus.

"The presence of respiratory viral infections in these four IPF patients suggests that a small minority of acute exacerbations of IPF may be caused by occult infection with common respiratory viruses," said Collard, who is also an assistant clinical professor of medicine at UCSF.

Unexpectedly, however, the authors also found that about one-quarter of both the acute IPF group and the acute lung infection group were infected with a common, typically symptomless virus known as the torque teno virus, or TTV. The virus was not found among any of the stable IPF patients.

The team cautioned that more research is needed to determine in what way TTV infection (which is usually associated with hepatitis) might be linked to IPF.

More information

For more on idiopathic pulmonary fibrosis, visit the U.S. National Heart, Lung and Blood Institute.

-- Alan Mozes

SOURCE: American Thoracic Society, news release, Feb. 25, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New vaccine technology protects mice from hepatitis C virus
2. Cold Viruses Appear Linked to Type 1 Diabetes
3. Virus might fight brain tumors better if armed with bacterial enzyme, study shows
4. Scientists decode secrets of a very common virus that can cause cancer
5. Flu Viruses Gaining Resistance, Study Confirms
6. Influenza virus strains show increasing drug resistance and ability to spread
7. BUSM researchers show an oncolytic virus switches off cancer cell survival signal
8. Potential new treatment for deadly nipah and hendra viruses identified by Weill Cornell researchers
9. Scientists investigate evolution of new polio virus
10. Haptoglobin as an early serum biomarker of virus-induced type 1 diabetes in rats
11. New Virus Jumps From Monkey to Scientist, Causing Serious Illness
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Virus Unlikely to Advance Deadly Lung Disease: Study
(Date:2/10/2016)... ... ... Dr. Jessica Barron, of Barron Family Dental in Thornton, Colorado , is ... the North Metro Denver area. The new dental practice focuses on comfort where patients ... the most relaxing environment. , While some dental visits can create anxiety for patients, ...
(Date:2/10/2016)... ... 2016 , ... United Benefit Advisors (UBA), the nation’s leading ... its growing list of Partner Firms. S.S. Nesbitt is headquartered in Birmingham, ... and in between. , Harnessing the experience and insights of the agency’s team ...
(Date:2/10/2016)... ... February 10, 2016 , ... Armune BioScience signed a definitive agreement ... laboratory service centers across the country. Launched in April of 2015, Apifiny is the ... prostate cancer. Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and ...
(Date:2/10/2016)... ... 2016 , ... For additional information contact Phyllis Strupp 480-488-5858 , Brain improves ... The Ultimate Guide to Brain Training" by award-winning author Phyllis Strupp explains ... is March 16, 2016. A free review copy is available to the media ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... Everseat digital self-scheduling readily available to physicians. The integration will enable ... find and select appointments via Everseat’s free mobile app. , The partnership gives ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... ATLANTA , Feb. 10, 2016  LexisNexis® ... and technology, today announced the launch of ... analytics solution that helps improve and optimize the ... evaluation of performance using severity-adjusted scores. By measuring ... a critical solution to deliver better outcomes, improve ...
(Date:2/10/2016)... , Feb. 10, 2016 Mast ... developing novel, clinical-stage therapies for sickle cell disease and ... public offering of 29,090,910 units at a price to ... of one share of the Company,s common stock and ... common stock at an exercise price of $0.42 per ...
(Date:2/10/2016)... , Feb. 10, 2016 ALSP, Inc. announced ... MD as Consultant for Medical Affairs in preparation for its ... Michael Pierschbacher , PhD, CEO, stated, "We are pleased to ... look forward to working with an individual of such practical ... look forward to drawing deeply on his broad experience and ...
Breaking Medicine Technology: